1. Home
  2. CERO vs SBEV Comparison

CERO vs SBEV Comparison

Compare CERO & SBEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • SBEV
  • Stock Information
  • Founded
  • CERO 2017
  • SBEV 1992
  • Country
  • CERO United States
  • SBEV United States
  • Employees
  • CERO N/A
  • SBEV N/A
  • Industry
  • CERO
  • SBEV Beverages (Production/Distribution)
  • Sector
  • CERO
  • SBEV Consumer Staples
  • Exchange
  • CERO Nasdaq
  • SBEV Nasdaq
  • Market Cap
  • CERO 12.2M
  • SBEV 10.9M
  • IPO Year
  • CERO N/A
  • SBEV N/A
  • Fundamental
  • Price
  • CERO $0.29
  • SBEV $0.18
  • Analyst Decision
  • CERO
  • SBEV Strong Buy
  • Analyst Count
  • CERO 0
  • SBEV 3
  • Target Price
  • CERO N/A
  • SBEV $1.50
  • AVG Volume (30 Days)
  • CERO 174.9M
  • SBEV 548.5K
  • Earning Date
  • CERO 11-25-2024
  • SBEV 11-26-2024
  • Dividend Yield
  • CERO N/A
  • SBEV N/A
  • EPS Growth
  • CERO N/A
  • SBEV N/A
  • EPS
  • CERO N/A
  • SBEV N/A
  • Revenue
  • CERO N/A
  • SBEV $6,257,725.00
  • Revenue This Year
  • CERO N/A
  • SBEV N/A
  • Revenue Next Year
  • CERO N/A
  • SBEV $182.15
  • P/E Ratio
  • CERO N/A
  • SBEV N/A
  • Revenue Growth
  • CERO N/A
  • SBEV N/A
  • 52 Week Low
  • CERO $0.06
  • SBEV $0.14
  • 52 Week High
  • CERO $12.80
  • SBEV $0.73
  • Technical
  • Relative Strength Index (RSI)
  • CERO 73.26
  • SBEV 36.18
  • Support Level
  • CERO $0.17
  • SBEV $0.19
  • Resistance Level
  • CERO $0.33
  • SBEV $0.23
  • Average True Range (ATR)
  • CERO 0.04
  • SBEV 0.03
  • MACD
  • CERO 0.02
  • SBEV 0.00
  • Stochastic Oscillator
  • CERO 57.68
  • SBEV 40.10

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About SBEV Splash Beverage Group Inc. (NV)

Splash Beverage Group Inc is a portfolio company managing multiple brands across several growth segments within the consumer beverage industry. The company's two reportable operating segments are: (1) the manufacture and distribution of non-alcoholic and alcoholic beverages, and (2) the retail sale of beverages and groceries online. The company generates the majority of its revenue from the E-Commerce segment. Qplash is a wholly owned division of Splash. It is the company's first entry point into the e-commerce channel. For beverage-alcohol products, the company operate within what is referred to as a "Three Tier Distribution System" where manufacturers are not permitted to sell directly to retailers, but instead, contract for local and regional distribution with independent distributors.

Share on Social Networks: